Selected research
Industry Growth & Trends
Global Tumor Registry Software Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Tumor Registry Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Tumor Registry Software is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Tumor Registry Software is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Tumor Registry Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Tumor Registry Software market include C/NET Solutions, Conduent Inc., Electronic Registry System Inc., Elekta, Himagine solutions, IBM Corporation, McKesson Corporation, NeuralFrame,Inc. and Onco Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Tumor Registry Software market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Tumor Registry Software market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tumor Registry Software market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tumor Registry Software.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Tumor Registry Software market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Tumor Registry Software Market by Company
C/NET Solutions
Conduent Inc.
Electronic Registry System Inc.
Elekta
Himagine solutions
IBM Corporation
McKesson Corporation
NeuralFrame,Inc.
Onco Inc.
Ordinal Data Inc.
Rocky Mountain Cancer Data Systems
Tumor Registry Software Segment by Type
On Premise
Cloud Based
Tumor Registry Software Segment by Application
Government and Third Party
Hospital and Medical Practice
Others
Tumor Registry Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor Registry Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tumor Registry Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor Registry Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Tumor Registry Software companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- On Premise
- Cloud Based
Applications
- Government and Third Party
- Hospital and Medical Practice
- Others
Companies covered
- C/NET Solutions
- Conduent Inc.
- Electronic Registry System Inc.
- Elekta
- Himagine solutions
- IBM Corporation
- McKesson Corporation
- NeuralFrame,Inc.
- Onco Inc.
- Ordinal Data Inc.
- Rocky Mountain Cancer Data Systems
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Tumor Registry Software Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Tumor Registry Software Market Size by Region (2021-2032)
- 1.4.1 Global Tumor Registry Software Market Size by Region (2021-2026)
- 1.4.2 Global Tumor Registry Software Market Size by Region (2027-2032)
- 1.5 Key Regions Tumor Registry Software Market Size (2021-2032)
- 1.5.1 North America Tumor Registry Software Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Tumor Registry Software Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Tumor Registry Software Market Size Growth Rate (2021-2032)
- 1.5.4 South America Tumor Registry Software Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Tumor Registry Software Market Size Growth Rate (2021-2032)
2 Tumor Registry Software Market by Type
- 2.1 Type Introduction
- 2.1.1 On Premise
- 2.1.2 Cloud Based
- 2.2 Global Tumor Registry Software Market Size by Type
- 2.2.1 Global Tumor Registry Software Market Size Overview by Type (2021-2032)
- 2.2.2 Global Tumor Registry Software Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Tumor Registry Software Market Size Forecasted by Type (2027-2032)
- 2.3 Global Tumor Registry Software Market Size by Regions
- 2.3.1 North America Tumor Registry Software Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Tumor Registry Software Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Tumor Registry Software Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Tumor Registry Software Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Tumor Registry Software Market Size Breakdown by Type (2021-2026)
3 Tumor Registry Software Market by Application
- 3.1 Type Introduction
- 3.1.1 Government and Third Party
- 3.1.2 Hospital and Medical Practice
- 3.1.3 Others
- 3.2 Global Tumor Registry Software Market Size by Application
- 3.2.1 Global Tumor Registry Software Market Size Overview by Application (2021-2032)
- 3.2.2 Global Tumor Registry Software Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Tumor Registry Software Market Size Forecasted by Application (2027-2032)
- 3.3 Global Tumor Registry Software Market Size by Regions
- 3.3.1 North America Tumor Registry Software Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Tumor Registry Software Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Tumor Registry Software Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Tumor Registry Software Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Tumor Registry Software Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Tumor Registry Software Industry Trends
- 4.2 Tumor Registry Software Industry Drivers
- 4.3 Tumor Registry Software Industry Opportunities and Challenges
- 4.4 Tumor Registry Software Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Tumor Registry Software Revenue (2021-2026)
- 5.2 Global Tumor Registry Software Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Tumor Registry Software Key Company Headquarters & Area Served
- 5.4 Global Tumor Registry Software Company, Product Type & Application
- 5.5 Global Tumor Registry Software Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Tumor Registry Software Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Tumor Registry Software Players Market Share by Revenue in 2025
- 5.6.3 2025 Tumor Registry Software Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 C/NET Solutions
- 6.1.1 C/NET Solutions Company Information
- 6.1.2 C/NET Solutions Business Overview
- 6.1.3 C/NET Solutions Tumor Registry Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 C/NET Solutions Tumor Registry Software Product Portfolio
- 6.1.5 C/NET Solutions Recent Developments
- 6.2 Conduent Inc.
- 6.2.1 Conduent Inc. Company Information
- 6.2.2 Conduent Inc. Business Overview
- 6.2.3 Conduent Inc. Tumor Registry Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Conduent Inc. Tumor Registry Software Product Portfolio
- 6.2.5 Conduent Inc. Recent Developments
- 6.3 Electronic Registry System Inc.
- 6.3.1 Electronic Registry System Inc. Company Information
- 6.3.2 Electronic Registry System Inc. Business Overview
- 6.3.3 Electronic Registry System Inc. Tumor Registry Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Electronic Registry System Inc. Tumor Registry Software Product Portfolio
- 6.3.5 Electronic Registry System Inc. Recent Developments
- 6.4 Elekta
- 6.4.1 Elekta Company Information
- 6.4.2 Elekta Business Overview
- 6.4.3 Elekta Tumor Registry Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Elekta Tumor Registry Software Product Portfolio
- 6.4.5 Elekta Recent Developments
- 6.5 Himagine solutions
- 6.5.1 Himagine solutions Company Information
- 6.5.2 Himagine solutions Business Overview
- 6.5.3 Himagine solutions Tumor Registry Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Himagine solutions Tumor Registry Software Product Portfolio
- 6.5.5 Himagine solutions Recent Developments
- 6.6 IBM Corporation
- 6.6.1 IBM Corporation Company Information
- 6.6.2 IBM Corporation Business Overview
- 6.6.3 IBM Corporation Tumor Registry Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 IBM Corporation Tumor Registry Software Product Portfolio
- 6.6.5 IBM Corporation Recent Developments
- 6.7 McKesson Corporation
- 6.7.1 McKesson Corporation Company Information
- 6.7.2 McKesson Corporation Business Overview
- 6.7.3 McKesson Corporation Tumor Registry Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 McKesson Corporation Tumor Registry Software Product Portfolio
- 6.7.5 McKesson Corporation Recent Developments
- 6.8 NeuralFrame,Inc.
- 6.8.1 NeuralFrame,Inc. Company Information
- 6.8.2 NeuralFrame,Inc. Business Overview
- 6.8.3 NeuralFrame,Inc. Tumor Registry Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 NeuralFrame,Inc. Tumor Registry Software Product Portfolio
- 6.8.5 NeuralFrame,Inc. Recent Developments
- 6.9 Onco Inc.
- 6.9.1 Onco Inc. Company Information
- 6.9.2 Onco Inc. Business Overview
- 6.9.3 Onco Inc. Tumor Registry Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Onco Inc. Tumor Registry Software Product Portfolio
- 6.9.5 Onco Inc. Recent Developments
- 6.10 Ordinal Data Inc.
- 6.10.1 Ordinal Data Inc. Company Information
- 6.10.2 Ordinal Data Inc. Business Overview
- 6.10.3 Ordinal Data Inc. Tumor Registry Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Ordinal Data Inc. Tumor Registry Software Product Portfolio
- 6.10.5 Ordinal Data Inc. Recent Developments
- 6.11 Rocky Mountain Cancer Data Systems
- 6.11.1 Rocky Mountain Cancer Data Systems Company Information
- 6.11.2 Rocky Mountain Cancer Data Systems Business Overview
- 6.11.3 Rocky Mountain Cancer Data Systems Tumor Registry Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Rocky Mountain Cancer Data Systems Tumor Registry Software Product Portfolio
- 6.11.5 Rocky Mountain Cancer Data Systems Recent Developments
7 North America
- 7.1 North America Tumor Registry Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Tumor Registry Software Market Size by Country (2021-2026)
- 7.3 North America Tumor Registry Software Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Tumor Registry Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Tumor Registry Software Market Size by Country (2021-2026)
- 8.3 Europe Tumor Registry Software Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Tumor Registry Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Tumor Registry Software Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Tumor Registry Software Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Tumor Registry Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Tumor Registry Software Market Size by Country (2021-2026)
- 10.3 South America Tumor Registry Software Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Tumor Registry Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Tumor Registry Software Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Tumor Registry Software Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst